(5-210) Evaluating The Risk of Cytokine Release Syndrome/Immune Effector Cell-Associated Neurotoxicity Syndrome with Expedited Bispecific-Antibody Administration and Impact of Tocilizumab Prophylaxis on Inpatient Length of Stay
Monday, December 8, 2025
4:15 PM - 5:15 PM
Location: Bayside A, Level 1
Pharmacy School: Long Island University Arnold and Marie Schwartz College of Pharmacy and Health Sciences Pharmacy School Location: New York